Antibacterial agents from Actinomycetes - A Review

Frontiers in Bioscience - Elite

Volumn 4 E, Issue 1, 2012, Pages 240-253

  Mahajan, Girish Badrinath ^a   Balachandran, Lakshmi ^b  

^a Piramal Enterprises Limited   (India)

^b Karmaveer Bhaurao Patil College   (India)

Author keywords

Actinomadura; Actinomycetes; Actinoplanes; Actinosporangium; Amycolatopsis; Antibiotics; Chromobacterium; Dactylosporangium; Faenia; Kibdelosporangium; Micromonospora; Nocardia; Planomonospora; Pseudonocardia; Ptilocaulis; Rare actinomycetes; Review; Saccharopolyspora; Saccharothrix; Sebekia; Streptomyces; Streptomycetes; Streptoverticillium

Indexed keywords

ABBISTRYN S; ABYSSOMICIN; ANTIBIOTIC AGENT; CARBOMYCIN; CHLORAMPHENICOL; CHLORTETRACYCLINE; CIPSTRYN S; CLARITHROMYCIN; CLINDAMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; DEMECLOCYCLINE; ERYTHROMYCIN; ESTREPTOMYCINA; FRAMYCETIN; GENTAMICIN; GRISEIN; ISOS; KANAMYCIN; KANAMYCIN B; LINCOMYCIN; NEOMYCIN; NOVOBIOCIN; OLEANDOMYCIN; OXYTETRACYCLINE; PLATENSIMYCIN; PM 181104; PYRIDOMYCIN; RAMOPLANIN; RIFAMYCIN; ROXITHROMYCIN; STREPTO FATOL; STREPTOMYCIN; TELAVANCIN; TIGECYCLINE; TITOMYCINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANCOMYCIN; ANTIINFECTIVE AGENT;

ACTINOBACTERIA; ACTINOMADURA; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; ATYPICAL MYCOBACTERIOSIS; BACTERIAL ENDOCARDITIS; BACTERICIDAL ACTIVITY; BRONCHIOLITIS; CHLAMYDIASIS; CHROMOBACTERIUM; DIFFUSE PANBRONCHIOLITIS; DRUG BIOAVAILABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPONATREMIA; INFECTION COMPLICATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MICROMONOSPORA; MICROMONOSPORA ECHINOSPORA; MICROMONOSPORA PURPUREA; NOCARDIA; NONHUMAN; PROTEIN SYNTHESIS; PROTEIN SYNTHESIS INHIBITION; RIBOSOME SUBUNIT; SACCHAROPOLYSPORA; SACCHAROPOLYSPORA ERYTHREA; SOFT TISSUE INFECTION; STREPTOMYCES; STREPTOMYCES AMBOFACIENS; STREPTOMYCES ANTIBIOTICUS; STREPTOMYCES AUREOFACIENS; STREPTOMYCES ERYTHREUS; STREPTOMYCES FRADIAE; STREPTOMYCES GRISEUS; STREPTOMYCES KANAMYCETICUS; STREPTOMYCES PLATENSIS; STREPTOMYCES ROSEOSPORUS; STREPTOMYCES VENEZUELAE; STREPTOTHRIX FOERSTERI; STREPTOVERTICILLIUM; TOXIC EPIDERMAL NECROLYSIS; TUBERCULOSIS; URINARY TRACT INFECTION; VANCOMYCIN RESISTANT ENTEROCOCCUS; VANCOMYCIN RESISTANT STAPHYLOCOCCUS AUREUS; CHEMISTRY; DRUG DEVELOPMENT; ISOLATION AND PURIFICATION; REVIEW; SCANNING ELECTRON MICROSCOPY; ULTRASTRUCTURE;

ACTINOBACTERIA (CLASS); ACTINOMADURA; ACTINOPLANES; AMYCOLATOPSIS; BACTERIA (MICROORGANISMS); CHROMOBACTERIUM; DACTYLOSPORANGIUM; FUNGI; KIBDELOSPORANGIUM; MICROMONOSPORA; NOCARDIA; PLANOMONOSPORA; PSEUDONOCARDIA; PTILOCAULIS; SACCHAROPOLYSPORA; SACCHAROTHRIX; SEBEKIA; STREPTOMYCES; STREPTOMYCINEAE;

ACTINOBACTERIA; ANTI-BACTERIAL AGENTS; DRUG DISCOVERY; MICROSCOPY, ELECTRON, SCANNING;

EID: 84860863055     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: 10.2741/e373     Document Type: Article

References (71)

1. Arnold L, Demain: Small bugs, big business: The economic power of the microbe. Biotechnol Adv 18, 499-514 (2000)
2. Selvameenal L, Radhakrishnan M, Balagurunathan R: Antibiotic pigment from desert soil actinomycetes; biological activity, purification and chemical screening. Indian J Pharm Sci 71, 499-504 (2009)
3. Castellani J J: America's Biopharmaceutical Research Companies' Medicines in development for infectious diseases 2010. September (2010)
4. Selman Waksman and antibiotics - ACS National Historical Chemical Landmarks (2007)
5. Cassell G H, Mekalanos J: Development of antimicrobial agentsin the era of new and reemerging infectious diseases and increasing antibiotic resistance. JAMA 285, 601-605 (2001)
6. Sivaramkrishna H, Girish Mahajan: Microbes An eternal source of innovative drugs. Express Pharma, 16-30 June (2009)
7. Stefano Donadio, Paolo Monciardini, Rosa Alduina, Paola Mazza, Claudia Chiocchini, Linda Cavaletti, Margherita Sosio, Anna Maria Puglia: Microbial technologies for the detection of novel bioactive metabolites. J Biotechnol 99, 187-198 (2002)
8. Selman A Waksman:On the classification of Actinomycetes. J Bacteriol 39(5), 549-558 (1940)
9. Williams ST, Goodfellow M,Alderson G, Wellington EMH, Sneath PHA, Sackin MJ: Numerical classification of Streptomyces and related genera. J. Gen. Microbiol129,1743-1813 (1983)
10. Williams ST, Goodfellow M, Alderson G: Genus Streptomyces Waksman and Henrici 1943, 339AL. In: Bergey's Manual of Systematic Bacteriology,Eds:Williams ST,Sharpe ME,Holt JG,Williams and Wilkins, Baltimore,Vol 4, 2452-2492 (1989)
11. Korn-Wendisch F,Kutzner HJ: The family Streptomycetaceae. In: The Prokaryotes, A Handbook on the Biology of Bacteria: Ecophysiology, Isolation, Identification, Application. Eds: Balows A, Truper HG, Dworkin M,Harder W, Schleifer KH, Springer Verlag, New York,Vol 1,2nd edn,921-995 (1992)
12. Ibrahim H Abbas: A Biological and Biochemical studies of Actinomycetes isolated from Kuwait saline soil-Kuwait. J. App. Sc Res 2(10), 809-815 (2006)
13. Buchanan R.E, Gibbons N.E:Bergey's Manual of determinative bacteriology, The Williams and Wilkins Co.,Baltimore, Eighth747-842 (1974)
14. Nonomura H:Key for classification and identificationof 458 species of the Streptomycetes included in the ISP.J Fermen. Technol 52(2), 78-92 (1974)
15. Rathna Kala G, Chandrika V: Effect of different media for isolation, growth and maintenance of actinomycetes from mangrove sediments. Indian J Mar. Sc., 22:297-299 (1993)
16. Shirling EB, Gottlieb D:Methods for characterization of Streptomycetes species. Int. J. Syst. Bacteriol, 16, 313-340 (1966)
17. http://taxonomicon.taxonomy.nl/TaxonTree.aspx
18. Selman A Waksman: Introductory. In: The Actinomycetes. The Williams and Wilkins company, USA, Volume I, VI-VII (1959)
19. Ronald C. Hamdy. Penicillin is 65 years old!, SMJ, 99(2), 192-193 (2006)
20. Selman A Waksman: Preface. In :The Actinomycetes. The Williams and Wilkins company, USA, Volume I, VIVII (1959)
21. Jie Jack Lee: Tiumph of the heart:the story of the statins, Oxford university press, USA, 59 (2009)
22. Selman A Waksman: Streptomycin: background, isolation, properties and utilization,Nobel lecture, 370-388 (1952)
23. Comroe J H Jr, Pay dirt : The story of Streptomycin, Part I. From Waksman to Waksman., Am Rev Respir Dis, 117(4), 773-81 (1978)
24. Hafizur Rahman, Brian Austin, Wilfrid J Mitchell, Peter C Morris, Derek J Jameison, David R Adams, Andrew Mearns Spragg and Michael Schweizer: Novel Anti-Infective Compounds from Marine Bacteria. Mar. Drugs, 8(3), 498-518 (2010)
25. http://www.chemnet.com/product/pclist-bekanamycin-0.html
26. Schumacher RW, Talmage SC, Miller SA, Sarris KE, Davidson BS,Goldberg A: Isolation and structure determination of an antimicrobial ester from a marinederived bacterium. J Nat Prod, 66, 1291-1293 (2003)
27. http://www.steadyhealth.com/encyclopedia/Carbomycin
28. J. Wongtavatchai, J.G. McLean, F. Ramos and D. Arnold: Chloramphenicol, WHO FOOD ADDITIVES SERIES: 53 (2004)
29. G Biffi, G Boretti, A Di Marcoand P Pennella: Metabolic behaviour and Chlorteracycline Production by Streptomyces aureofaciens in Liquid culture. Appl. Microbio, Sep issue, 288-293 (1954)
30. http://www.merck.com/mmpe/lexicomp/clindamycin.html
31. Vivian Miao, Marie-Francoise Coeffet-LeGal, Paul Brian, Renee Brost, Julia Penn, Andrew Whiting, Steven Martin, Robert ford, Ian Parr, Mario Bouchard, Christopher J Silva, Stephen K Wrigley and Richard H Baltz: Daptomycin Biosynthesis in Streptomyces roseosporus: cloning and analysis of the gene cluster revision of peptide stereochemistry, Microbiol, 151, 1507-1523 (2005)
32. http://www.rxlist.com/erythromycin-ethylsuccinatedrug.htm
33. http://www.actavis.bg/NR/rdonlyres/CE60D855-315B-4693-A465-22F17D5871EF/ 0/ramycetinSulphateSPCen.pdf
34. Gonzalez R, Isla L, Obregon A AM, Escalante L, Sanchez S, Gentamicin formation in Micromonospora purpurea : stimulatory effect of ammonium. J. Antibiot., 48(6), 479-839 (1995)
35. Donald M Reynolds and Selman A Waksman: Grisein, an antibiotic produced by certain strains of Streptomyces griseus. J. Bac., 55(5), 739- 752 (1948)
36. Ketaki Basak and S. K. Majumdar:Utilization of Carbon and Nitrogen Sources by Streptomyces kanamyceticus for Kanamycin Production. Antimicrob. Agents. Chemother., 4(1), 6-10 (1973)
37. J Spizek and T Rezanka: Lincomycin, cultivation of producing strains and biosynthesis. App. Microbiol. Biotechnol, 63(5), 510-519 (2004)
38. Selman A Waksman, Walton B Geiger, Elizabeth Bugie: Micromonosporin, an antibiotic from a little-known group of microorganisms. J. Bacterio, 53(3), 355-357 (1947)
39. http://www.drugs.com/mtm/neomycin.html
40. Steffensky M, Mühlenweg A, Wang ZX, Li SM, Heide L: Identification of the novobiocin biosynthetic gene cluster of Streptomyces spheroides NCIB 11891. Antimicrob. Agents Chemother. 44 (5): 1214-22 (2000)
41. Luis M Quirs and Jos A Salas: Biosynthesis of Macrolide Oleandomycin by Streptomyces antibioticus: Purification and kinetic characterisation of an Oleandomycin Glucosyltransferase. J. Biol. Chem. 270,18234- 18239 (1995)
42. Zygmunt W A: Oxytetracycline formation by Streptomyces rimosus in Chemically Defined Media. Appl. Microbiol, 9(6): 502-507 (1961)
43. Hiroshi, Ogawara, Kenji, Maeda, Hamao, Umezawa: Biosynthesis of Pyridomycin I. Biochem, 7(9), 3296-3302 (1968)
44. G. B. Mahajan, S. D. George, P. Ranadive, P. D. Mishra, E. Sreekumar, R. M. Panshikar, S. N. Sawant, S. Krishna, M. Sivakumar, K. Pari, B. Thomas, Z. Patel, R. A. Vishwakarma, C. G. Naik, L. D'Souza, P. Devi (Piramal Life Sciences Limited, Mumbai and NIO, Goa): PM181104 and related antibacterial compounds, production, pharmaceutical compositions, and therapeutic use. PCT Int. Appl. WO 2007119201 (2007)
45. D.K. Farver, D.D. Hedge, S.C. Lee: Ramoplanin: a lipoglycodepsipeptide antibiotic. Ann. Pharmacother 39(5), 863-8 (2005)
46. S. Bala, R. Khanna, M Dadhwal, S R Prabhagaran, S Shivaji, John Cullum and Rup Lal : Reclassification of "Amycolatopsis mediterranei" DSM 46095 as "Amycolatopsis rifamycinica" sp. Int. J. Syst. Evol. Microbiol.54, 1145-1149 (2004)
47. From the Centers for Disease Control and Prevention.Update on spectinomycin availability in the United States. JAMA, 286(11), 1308-9 (2001)
48. Anissa Lounès, Ahmed Lebrihi, Chouki Benslimane, Gerard Lefebvre and Pierre Germain: Glycerol effect on spiramycin production and valine catabolism in Streptomyces ambofaciens. Curr. Microbiol. 31(5), 304-311 (1995)
49. A. B. Kupferberg, H. Styles, H. O. Singher and S. A. Waksman: The production of Streptocin by different strains of Streptomyces griseus. J. Bacteriol. 59(4), 523-526 (1950)
50. http://www.merck.com/mmpe/print/sec14/ch170/ch170g.html
51. S. A. Waksman, Production and activity of Streptothricin, J. Bacteriol. 46(3), 299-310 (1943)
52. http://www.aic.cuhk.edu.hk/web8/glycopeptides.htm
53. Hiroshi Sasaki, Hideo Oishi, Toshiaki Hayashi, Ikutoshi matsuura, Kunio Ando, Mikio Sawada.Thiolactomycin, a new antibiotic. J. Ant. 35, (4), 396-400 (1982)
54. Bryan Anderson, Dorothy Crawfoot Hodgkinand M A Viswamitra, The structure of Thiostrepton, Nature, 225 : 233-235 (1970)
55. Levine D: Vancomycin : A History. Clin. Infect. Dis., 42: S5-S12 (2006)
56. Association of mutations in rpsL gene with high degree of streptomycin resistance in Clinical isolates of Mycobacterium tuberculosis in India, Indian J. Med. Res., 129, 108-110 (2009)
57. http://www.mims.com/Page.aspx?menuid=mng&name=streptomycin#AvlBrands
58. http://www.rxmed.com/b.main/b2.pharmaceutical/b2.1. monographs/CPS- %20Monographs/CPS-%20(General%20Monographs-%20C)/CHLORAMPHENICOL.html
59. http://clinicaltrials.gov/
60. Jan G. den Hollander, Jenny D Knudsen, Johan W Mouton,Kurt Fuursted, Neils Frimodt-Møller, Henri A Verbrugh and Frank Espersen: Comparision of Pharmacodynamics of Azithromycin and Erythromycin In vitro and In vivo, Antimicrob. Agents. Chemother .42 (2), 377-382 (1998)
61. Ying, Lu, Tang, Datong: Recent Advances in the Medicinal Chemistry of Novel Erythromycin- Derivatized Antibiotics, Bentham Science Publishers, 10 (14), 1441-1469 (2010)
62. Keicho N, Kudoh S, Diffuse panbronchiolitis: role of macrolides in therapy, Am. J. Respir. Med., 1(2), 119-31 (2002)
63. Mu Y, Nodwell M, Pace J, Shaw JP, Judice K: Vancomycin Disulfide Derivatives as Antibacterial Antibacterial agents. Abstr Intersci Conf Antimicrob Agents Chemother, 42: 368 (2002)
64. http://www.drugs.com/nda/telavancin-080306.html
65. http://www.healthline.com/goldcontent/kanamycin/2?brand
66. William O Foye, Thomas L Lemke, David A Williams: Advances in Carbohydrate Chemistry and Biochemistry. Vol 48: 12, (1990)
67. G H Wagman: Antibiotics from Micromonospora. Ann Rev Microbiol, 34, 537-557 (1980)
68. http://clinicalpharmacy.ucsf.edu/idmp/whatsnew/dapto-monograph.htm
69. Annual report, Cubist Pharmaceuticals. http://biz.yahoo.com/e/100226/ cbst10-k.html
70. David J Newman and Gordon M Cragg: Natural Products as Sources of New Drugs over the last 25 years. J Nat Prod 70, 461-477 (2007)
71. Kalanidhi Palanichamy, Krishna P Kaliappan:Discovery and syntheses of "Superbug challengers"-Platensimycin and Platencin.Chemistry-An Asian Jour., 5(4), 668-703 (2010)